Cargando…
Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development an...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613998/ https://www.ncbi.nlm.nih.gov/pubmed/36109648 http://dx.doi.org/10.1038/s41589-022-01118-z |
_version_ | 1783605551138078720 |
---|---|
author | Lo, Wen-Ting Belabed, Hassane Kücükdisli, Murat Metag, Juliane Roske, Yvette Prokofeva, Polina Ohashi, Yohei Horatscheck, André Cirillo, Davide Krauss, Michael Schmied, Christopher Neuenschwander, Martin von Kries, Jens Peter Médard, Guillaume Kuster, Bernhard Perisic, Olga Williams, Roger L. Daumke, Oliver Payrastre, Bernard Severin, Sonia Nazaré, Marc Haucke, Volker |
author_facet | Lo, Wen-Ting Belabed, Hassane Kücükdisli, Murat Metag, Juliane Roske, Yvette Prokofeva, Polina Ohashi, Yohei Horatscheck, André Cirillo, Davide Krauss, Michael Schmied, Christopher Neuenschwander, Martin von Kries, Jens Peter Médard, Guillaume Kuster, Bernhard Perisic, Olga Williams, Roger L. Daumke, Oliver Payrastre, Bernard Severin, Sonia Nazaré, Marc Haucke, Volker |
author_sort | Lo, Wen-Ting |
collection | PubMed |
description | Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development and characterization of PhosphatidylInositol Three-kinase Class twO INhibitors (PITCOINs), potent and highly selective small-molecule inhibitors of PI3KC2α catalytic activity. PITCOIN compounds exhibit strong selectivity toward PI3KC2α due to their unique mode of interaction with the ATP-binding site of the enzyme. We demonstrate that acute inhibition of PI3KC2α-mediated synthesis of phosphatidylinositol 3-phosphates by PITCOINs impairs endocytic membrane dynamics and membrane remodeling during platelet-dependent thrombus formation. PITCOINs are potent and selective cell-permeable inhibitors of PI3KC2α function with potential biomedical applications ranging from thrombosis to diabetes and cancer. [Image: see text] |
format | Online Article Text |
id | pubmed-7613998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-76139982022-12-30 Development of selective inhibitors of phosphatidylinositol 3-kinase C2α Lo, Wen-Ting Belabed, Hassane Kücükdisli, Murat Metag, Juliane Roske, Yvette Prokofeva, Polina Ohashi, Yohei Horatscheck, André Cirillo, Davide Krauss, Michael Schmied, Christopher Neuenschwander, Martin von Kries, Jens Peter Médard, Guillaume Kuster, Bernhard Perisic, Olga Williams, Roger L. Daumke, Oliver Payrastre, Bernard Severin, Sonia Nazaré, Marc Haucke, Volker Nat Chem Biol Article Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development and characterization of PhosphatidylInositol Three-kinase Class twO INhibitors (PITCOINs), potent and highly selective small-molecule inhibitors of PI3KC2α catalytic activity. PITCOIN compounds exhibit strong selectivity toward PI3KC2α due to their unique mode of interaction with the ATP-binding site of the enzyme. We demonstrate that acute inhibition of PI3KC2α-mediated synthesis of phosphatidylinositol 3-phosphates by PITCOINs impairs endocytic membrane dynamics and membrane remodeling during platelet-dependent thrombus formation. PITCOINs are potent and selective cell-permeable inhibitors of PI3KC2α function with potential biomedical applications ranging from thrombosis to diabetes and cancer. [Image: see text] Nature Publishing Group US 2022-09-15 2023 /pmc/articles/PMC7613998/ /pubmed/36109648 http://dx.doi.org/10.1038/s41589-022-01118-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lo, Wen-Ting Belabed, Hassane Kücükdisli, Murat Metag, Juliane Roske, Yvette Prokofeva, Polina Ohashi, Yohei Horatscheck, André Cirillo, Davide Krauss, Michael Schmied, Christopher Neuenschwander, Martin von Kries, Jens Peter Médard, Guillaume Kuster, Bernhard Perisic, Olga Williams, Roger L. Daumke, Oliver Payrastre, Bernard Severin, Sonia Nazaré, Marc Haucke, Volker Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title | Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title_full | Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title_fullStr | Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title_full_unstemmed | Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title_short | Development of selective inhibitors of phosphatidylinositol 3-kinase C2α |
title_sort | development of selective inhibitors of phosphatidylinositol 3-kinase c2α |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613998/ https://www.ncbi.nlm.nih.gov/pubmed/36109648 http://dx.doi.org/10.1038/s41589-022-01118-z |
work_keys_str_mv | AT lowenting developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT belabedhassane developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT kucukdislimurat developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT metagjuliane developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT roskeyvette developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT prokofevapolina developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT ohashiyohei developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT horatscheckandre developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT cirillodavide developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT kraussmichael developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT schmiedchristopher developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT neuenschwandermartin developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT vonkriesjenspeter developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT medardguillaume developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT kusterbernhard developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT perisicolga developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT williamsrogerl developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT daumkeoliver developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT payrastrebernard developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT severinsonia developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT nazaremarc developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a AT hauckevolker developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a |